DrugCard

DrugCard

4.5
(120 reviews)

Streamline Drug Safety with AI-Driven Solutions

DrugCard offers comprehensive literature screening and pharmacovigilance solutions, emphasizing effective in-house management or minimal outsourcing to enhance compliance and efficiency in drug safety processes. It aims to upgrade outdated practices with innovative methodologies and tools.

Education & LearningResearchDrugCardliterature screeningpharmacovigilance

Overview

DrugCard is a comprehensive literature screening and pharmacovigilance solution designed to streamline drug safety routines for pharmaceutical companies. It offers continuous, regular, and transparent screening processes in multiple languages, making it a cost-effective choice for organizations facing increasing compliance demands.

Key features of DrugCard include AI-driven automated solutions, a simple search function, regulatory intelligence, and an adverse event database. These tools are essential for ensuring full compliance with regulatory requirements, especially as the landscape of pharmacovigilance evolves rapidly.

The target audience for DrugCard includes pharmaceutical companies and contract research organizations (CROs) that are looking to enhance their literature screening practices. With the growing complexity of drug safety processes and the pressures of global regulations, DrugCard provides a reliable alternative to traditional methods.

Main benefits of using DrugCard include improved efficiency in literature screening, reduced compliance risks, and the ability to manage drug safety processes in-house or with minimal contractors. By upgrading obsolete screening practices, DrugCard helps its customers achieve high-performance methodologies and tools, ultimately ensuring satisfaction and compliance in a challenging environment.

Screenshots & Videos

Homepage screenshot of https://drug-card.io/

Pricing Plans

Basic PlanPro Plan
Contact for pricing
USD
Monthly
Contact for pricing
USD
Monthly

No details available

No details available

Pros (7)

  • Continuous, regular, and transparent literature screening
  • Multi-language support
  • Cost-effective solution for literature screening
  • Helps install new standards and high-performance screening methodology
  • Promotes upgrading obsolete screening practices
  • Streamlines drug safety routines
  • Addresses global pressures and new requirements in drug safety processes

Cons (5)

  • Growth has slowed due to aggressive entrants with AI-tech
  • Longer paybacks on heavy investments
  • Increased number of audits and non-compliance cases
  • Higher retention costs due to good people leaving
  • Longer and less predictable market entry

Reviews & Ratings

No reviews yet — be the first to review.

Visit DrugCard to leave a review

Top AI tools for DrugCard

Loading...

FAQs